Book by 30 June 2026 and get a 10% early-bird discount on all events starting on or after 25 August 2026. To the promotion
GMP search engine – look up GMP compliance regulations and news
Balances - Correction of the Requirements in the U.S. Pharmacopoeia (USP)
Recommendation
9-11 June 2026
Development, Validation & Control
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In the Pharmacopoeial Forum 40(1) a short-term revision of the General Chapter <41> with regard to balances was announced as "interim revision announcement".
Questions that arrived at the USP indicate that there is a potential problem with the requirement of repeatability in the verification of scales. If you follow the procedure as described, the use of a large test weight can cause false positive results.
To resolve this problem, the expert group of the USP proposes a modified test in which the "smallest desired net weight" is now incorporated in the formula for the repeatability as well.
If there are no contrary comments, this "interim revision announcement" will become effective as of 1 July 2014.
All other information are available on the USP website of the Pharmacopeial Forum (PF).
Source: USP - http://www.USP.org
Related GMP News
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation
21.05.2026LCGC Article on Analytical Procedure Lifecycle Approaches